AUBREIGH GODLESKI: Open Payments
NPI 1346719622 · PHILLIPSBURG, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 11 payments from 4 companies in 2025. Trend: 2023 $345 · 2024 $720 · 2025 $190
Food & beverage: $190
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $92 |
| Neurocrine BioSciences, Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: VRAYLAR, INGREZZA, TRINTELLIX, INVEGA SUSTENNA.
Industry payments across NJ — which companies pay providers there.
